CLEAR CELL PAPILLARY RENAL CELL CARCINOMA

This adverse event was reported 13 times

CLEAR CELL PAPILLARY RENAL CELL CARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 VADADUSTAT 1 0.0033
1 CLADRIBINE 1 0.0001
2 FEBUXOSTAT TABLETS 40 MG 1 0.0001
3 METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA 1 0.0001
4 EMPAGLIFLOZIN 6 0.0001
5 FEBUXOSTAT 1 0.0001
6 DULAGLUTIDE 5 0.0001
7 RABEPRAZOLE SODIUM 1 0.0000
8 TORSEMIDE 1 0.0000
9 GUSELKUMAB 1 0.0000
See all drugs enriched for association with CLEAR CELL PAPILLARY RENAL CELL CARCINOMA